Baxter International | BAX - Nettoeinkommen





Nettoeinkommen Veränderung Datum
Abbott USD 928M 149M 2026-06
AngioDynamics USD -6.35M 4.55M 2025-09
Artivion USD 2.42M 4.07M 2025-12
AtriCure USD 8.96M 8.85M 2026-06
Avanos Medical USD 5.1M 6.4M 2026-03
Baxter International USD -15M 1.11B 2026-03
Becton, Dickinson and Co. USD -311M 693M 2026-03
Boston Scientific USD 1.34B 669M 2026-03
Cooper Companies USD -77.9M 208.7M 2026-03
Dexcom USD 199.5M 67.8M 2026-03
Edwards Lifesciences USD 241.9M 138.8M 2026-06
Fresenius EUR 361M 17M 2025-12
Globus Medical USD 140.59M 21.63M 2025-12
Halozyme Therapeutics USD 150.05M 291.64M 2026-03
ICU Medical USD -15.73M 12.34M 2025-12
Inogen USD -5.96M 373K 2024-09
Insulet USD 91.1M 10.5M 2026-03
Integra LifeSciences USD -4.62M 2.91M 2026-03
Intuitive Surgical USD 818.1M 3.4M 2026-06
J&J USD 5.53B 299M 2026-06
Laboratory Of America USD 277.8M 113.1M 2026-03
Medtronic USD 1.24B 100M 2026-03
Merit Medical Systems USD 41M 2.99M 2026-03
Quest Diagnostics USD 320M 69M 2026-06
Smith & Nephew USD 293M 79M 2025-12
Stryker USD 745M 104M 2026-03
Tandem Diabetes Care USD -589K 20.58M 2025-12
Teleflex USD -8.15M 706.18M 2026-03
Terumo JPY 26.37B 6.28B 2026-03
Zimmer Biomet Holdings USD 238.1M 98.8M 2026-03